Erythropoietin drug market Prediction and Analysis Offered By New Study Throughout 2027

 

Worldwide Sales of Erythropoietin Drugs to Remain Strong, Asserts MRFR

The worldwide demand for erythropoietin drugs also referred as hematopoietin drugs is expected to remain strong in the forthcoming years. Market Research Future (MRFR) reports that the global erythropoietin drug market will post a above-average CAGR  between 2017 and 2023. The outlook remains positive for the global erythropoietin drug market for the medium terms.

Erythropoietin drug are used for treating a wide-range of disorders, which include AIDS, chronic renal diseases, anaemia, cancer, among others. Increased prevalence of such diseases is boosting the sales of erythropoietin. Over the years, tremendous investment has been made in research & development programs focused on drug discovery, which has also influenced the market growth to certain extent.   Several new erythropoietin drug combinations have come up in recent years. Introduction of new drug combinations is allowing to drug makers to cater to wider pool of patients.

Rising awareness among patients and increased focus on improving healthcare services in the developing countries is likely to open new growth avenues for market players in near future. On the other hand, most of the erythropoietin drug available are highly priced, which makes their penetration in price sensitive markets difficult. This is viewed as a major market constraint. Patient expiry and introduction of generic variants may provide an impetus to drug penetration. Focus is also shifting on developing alternative drugs formulations.

 

Segmental Overview

MRFR’s report includes a thorough segmental analysis of the global erythropoietin drug market based on product type, application and end user.

On the basis of product type, the market has been segmented into second generation formulation, first generation formulation and biosimilars. On the basis of application, the market has been segmented into renal diseases, HIV, oncology and other. On the basis of end user, the market has been segmented into pharmacy and hospital.

 

Global Erythropoietin Drug Market: Regional Segmentation

On the basis of region, the market has been segmented into North America, South America, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA). North America represents the largest market for Erythropoietin. This growth can be partly attributed to rising cancer prevalence and increased incidence of renal diseases in the U.S. and Canada. Other factors that favour the market growth in the region include widespread accessibility of cutting-edge medical services and strong government support. North America is followed by Europe and APAC respectively. The market is likely to witness towering gains in APAC in particular. In addition, the APAC erythropoietin drug market is projected to exhibit the fastest growth during the forecast period. Increased penetration of healthcare services and expanding patient population in countries such as China and India. Moreover, increased government effort to improve healthcare in these countries is creating further opportunities. LatAm and the MEA regions hold relatively lower share of the global erythropoietin drug market.

Access Report Details @ https://www.marketresearchfuture.com/reports/erythropoietin-drug-market-1360

Competitive Landscape  

Amgen (US), Teva Pharmaceutical Industries Ltd. (Israel), Emcure Pharmaceuticals (India), Hospira (US), LG Life Sciences Ltd. (Korea), Kyowa Hakko Kirin, Boehringer Ingelheim (US), Intas Pharmaceuticals (India), Hoffmann-La Roche (Switzerland), Johnson & Johnson (US), Celltrion, Inc. (South Korea), 3SBio, Biocon (India), BIOSIDUS (Argentina), and Dahua Pharmaceutical (China).

·         Reportedly, well before any other country, China approves a new anaemia drug “Roxadustat” from FibroGen and AstraZeneca. Roxadustat supports a novel oral anaemia treatment known as hypoxia-inducible factor prolyl hydroxylase inhibitor. The drug is viewed as a convenient alternative to erythropoietin or EPO.

·         AstraZeneca has recently partnered with UK-based artificial intelligence specialist BenevolentAI. The partnership will allow AstraZeneca to leverage machine learning and AI for drug discovery projects focusing on idiopathic pulmonary fibrosis (IPF) and chronic kidney disease (CKD).

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

 

Comments

Post a Comment

Popular posts from this blog

Organic Soybean Market value, Share, Size, Competition Landscape, Manufacturers Analysis and Future Opportunity Outlook – 2027

  Overview: The global organic soybean market is touted to reach a total market valuation of USD 2210.53 million by 2022. A stellar CAGR of 17.71% the organic soybean market is about to achieve during the forecast period. Market Research Future (MRFR) in their report on the organic soybean market includes soybeans high nutritional value as a significant market contributor. Furthermore, with people growing health conscious all around, healthy chemical-free products are gaining traction both as human consumables and animal feed. This is playing a crucial role in giving a head start to an organic soybean market. At the same time, apart from being a much-desired food component, personal care & cosmetic, pharmaceutical, and other sectors are also opening up a market opportunity for organic soybean.    On the flip side, price volatility of such products can always become a challenge for smooth market growth during the forecast period. Price of grains is varying much d...
Read more

North America and Europe Smart Kitchen Appliances Market Outlook, Key Trends, Demand and Forecast to 2028

The North America and Europe smart kitchen appliances market is expected to exhibit steady growth over the forecast period due to the growing consumer inclination towards the use of wireless connectivity for kitchen-based applications. This information comes from the latest research report from Market Research Future (MRFR). The MRFR report provides a comprehensive overview of the smart kitchen appliances market’s historical growth trajectory in North America and Europe, elaborating upon the major drivers and restraints affecting the market. The immediate economic environment of the smart kitchen appliances market is also studied in the report in order to provide readers with pointers as to how major macroeconomic and microeconomic factors impact the smart kitchen appliances market. The leading players operating in the North America and Europe smart kitchen appliances market are also studied in the report to provide readers with a clear picture of the competitive landscape of the marke...
Read more

Semolina Market Growth Outlook, Segments Share Analysis, Market Scenario Forecast 2020-2027

  Market Forecast Global Semolina Market size is projected to be valued at USD 2,260.09 Million by 2026 at a CAGR of 2.3% between 2020 and 2026. Semolina is a coarse flour made from either wheat, rice, or corn. It is used as part of both sweet and savory foods, has high nutritional content, and offers a healthy choice for the health-conscious population. The demand for semolina is increasing with the rising consumption of wheat products. Semolina is the main ingredient in several fast food products such as pasta, noodles, and breakfast cereals. The high consumption of these products has propelled the demand for semolina across the globe. Furthermore, semolina is inexpensive and is easily available to consumers belonging to all social-economical groups. Also, the gluten-sensitive population can opt for rice-based semolina. These benefits are likely to drive the demand for semolina market growth during the forecast period. Market USP High nutritional content Growth Oppor...
Read more